Literature DB >> 25796511

A multiplex ELISA-based protein array for screening diagnostic antigens and diagnosis of Flaviviridae infection.

D Wang1, Y Zheng, X Kang, X Zhang, H Hao, W Chen, L Liu, X Li, L Li, Q Yuan, F Chen, Y Yang, Y Jiang, H Jiang.   

Abstract

Assays with the ability to detect multiple antibodies in parallel have a wide range of potential applications in epidemiologic research. Here, a multiplex enzyme-linked immunosorbent assay-based protein array (ELISA-array) was developed to simultaneously detect five Flaviviridae infections. The platform was based on an indirect ELISA and 15 antigens were constructed for specific antibody detection against five Flaviviridae viruses (Japanese B, tick-borne encephalitis, West Nile, dengue, and yellow fever viruses) and four serotypes of dengue virus. The specificity was evaluated by calculating the signal value cross-reacting with serum immunized with other viruses, and the sensitivity of antigens was compared with conventional ELISAs using immunized rabbit polyclonal antisera. IgG and IgM calibration curves were constructed to evaluate the reproducibility of the platform. Finally, 24 dengue fever (DF) infection and 15 tick-borne encephalitis (TBE) infection clinical sera were used to compare the advantage of ELISA-array to ELISA. After initial screening, 9 out of 15 antigens were chosen for ELISA-array printing. By using different virus-immunized rabbit antiserum, 7 out of 9 antigens showed good specificity in the ELISA-array. Eight out of 9 antigens showed four-fold greater sensitivity in ELISA-array compared to that in conventional ELISAs. The coefficients of determination (r (2)) close to 1 showed high reproducibility, and clinical sera test showed that ELISA-array had higher specificity and sensitivity than traditional ELISA. ELISA-array was a good platform for antigen screening and this multiplexed assay might be a useful and convenient tool for multiple immunological detection of infectious viral antibodies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25796511     DOI: 10.1007/s10096-015-2353-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  25 in total

1.  Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells.

Authors:  W D Crill; J T Roehrig
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  A walk on the wild side--emerging wildlife diseases.

Authors:  Andrew A Cunningham
Journal:  BMJ       Date:  2005-11-26

3.  Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model.

Authors:  C W Mandl; F Guirakhoo; H Holzmann; F X Heinz; C Kunz
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Evaluation of recombinant LigB antigen-based indirect ELISA and latex agglutination test for the serodiagnosis of bovine leptospirosis in India.

Authors:  Yosef Deneke; T Sabarinath; Neha Gogia; Jonathan Lalsiamthara; K N Viswas; Pallab Chaudhuri
Journal:  Mol Cell Probes       Date:  2014-01-18       Impact factor: 2.365

Review 5.  Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization.

Authors:  Juliana Helena Chávez; Jaqueline Raymondi Silva; Alberto Anastacio Amarilla; Luiz Tadeu Moraes Figueiredo
Journal:  Biologicals       Date:  2010-11       Impact factor: 1.856

6.  Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.

Authors:  Theodore Oliphant; Grant E Nybakken; Michael Engle; Qing Xu; Christopher A Nelson; Soila Sukupolvi-Petty; Anantha Marri; Bat-El Lachmi; Udy Olshevsky; Daved H Fremont; Theodore C Pierson; Michael S Diamond
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

7.  Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.

Authors:  Gregory D Gromowski; Alan D T Barrett
Journal:  Virology       Date:  2007-08-23       Impact factor: 3.616

8.  Validating a custom multiplex ELISA against individual commercial immunoassays using clinical samples.

Authors:  Michael Liew; Matthew C Groll; James E Thompson; Sara L Call; Joann E Moser; Justin D Hoopes; Karl Voelkerding; Carl Wittwer; Rex S Spendlove
Journal:  Biotechniques       Date:  2007-03       Impact factor: 1.993

9.  Liao ning virus in China.

Authors:  Zhi Lu; Hong Liu; Shihong Fu; Xinjun Lu; Qiang Dong; Song Zhang; Suxiang Tong; Minghua Li; Wenjuan Li; Qing Tang; Guodong Liang
Journal:  Virol J       Date:  2011-06-08       Impact factor: 4.099

10.  Molecular archaeology of Flaviviridae untranslated regions: duplicated RNA structures in the replication enhancer of flaviviruses and pestiviruses emerged via convergent evolution.

Authors:  Dmitri J Gritsun; Ian M Jones; Ernest A Gould; Tamara S Gritsun
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more
  5 in total

Review 1.  Progress and Challenges towards Point-of-Care Diagnostic Development for Dengue.

Authors:  Junxiong Pang; Po Ying Chia; David C Lye; Yee Sin Leo
Journal:  J Clin Microbiol       Date:  2017-09-13       Impact factor: 5.948

Review 2.  Label-Free Electrochemical Biosensors for the Determination of Flaviviruses: Dengue, Zika, and Japanese Encephalitis.

Authors:  Ekaterina Khristunova; Elena Dorozhko; Elena Korotkova; Bohumil Kratochvil; Vlastimil Vyskocil; Jiri Barek
Journal:  Sensors (Basel)       Date:  2020-08-16       Impact factor: 3.576

3.  Efficient Plant Production of Recombinant NS1 Protein for Diagnosis of Dengue.

Authors:  Mariana Fonseca Xisto; Roberto Sousa Dias; Elias Feitosa-Araujo; John Willians Oliveira Prates; Cynthia Canedo da Silva; Sérgio Oliveira de Paula
Journal:  Front Plant Sci       Date:  2020-10-26       Impact factor: 5.753

4.  Comparing machine learning with case-control models to identify confirmed dengue cases.

Authors:  Tzong-Shiann Ho; Ting-Chia Weng; Jung-Der Wang; Hsieh-Cheng Han; Hao-Chien Cheng; Chun-Chieh Yang; Chih-Hen Yu; Yen-Jung Liu; Chien Hsiang Hu; Chun-Yu Huang; Ming-Hong Chen; Chwan-Chuen King; Yen-Jen Oyang; Ching-Chuan Liu
Journal:  PLoS Negl Trop Dis       Date:  2020-11-10

Review 5.  Novel Approaches to an Integrated Route for Trisomy 21 Evaluation.

Authors:  Angelika Buczyńska; Iwona Sidorkiewicz; Anna Trochimiuk; Sławomir Ławicki; Adam Jacek Krętowski; Monika Zbucka-Krętowska
Journal:  Biomolecules       Date:  2021-09-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.